Alan T. Nurden

Papers

Total Citations

H-Index

About

Alan T. Nurden is a leading figure in platelet biology and hemostasis, whose research has fundamentally shaped our understanding of inherited bleeding disorders and thrombosis. His key contributions center on the structure, function, and pathology of platelet membrane glycoproteins, particularly in Glanzmann thrombasthenia and Bernard-Soulier syndrome. Nurden’s pioneering work elucidated the molecular basis of these disorders, identifying critical defects in integrin αIIbβ3 and the GPIb-IX-V complex. His studies have been instrumental in defining how platelet receptors mediate adhesion and aggregation, with his landmark papers accumulating thousands of citations—a testament to their enduring influence. Notably, his 2004 review in the *Journal of Thrombosis and Haemostasis* remains a cornerstone reference for clinicians and researchers. Beyond basic science, Nurden has advanced clinical diagnostics and therapeutic strategies, including the use of recombinant factor VIIa. His collaborative efforts have also explored novel antibody-based approaches for targeting atherosclerotic lesions, as seen in his 2006 work on human scFvs. A prolific author and mentor, Nurden’s legacy lies in bridging molecular mechanisms with patient care, making him an indispensable resource for students and scientists studying platelet disorders.